Eplerenone reduces renal ischaemia/reperfusion injury by modulating Klotho, NF-κB and SIRT1/SIRT3/PGC-1α signalling pathways

Objectives Acute kidney injury (AKI) is a sudden impairment in kidney function that is associated with high morbidity and mortality. Inflammation, oxidative stress, mitochondrial impairment and energy depletion, along with organ dysfunction are hallmarks of AKI. This study aimed to evaluate the effects of Eplerenone, an aldosterone receptor antagonist, on the kidney injury caused by ischaemia/reperfusion (I/R). Methods Male Wistar rats (n = 24) were randomly allocated into four groups: sham, IR, Eplerenone and Eplerenone+IR. Rats in the two last groups 1 h before I/R induction, were treated with Eplerenone (100 mg/kg) via intraperitoneal injection. Protein levels of Klotho, heat shock protein 70 (HSP70), sirtuin1 (SIRT1), SIRT3 and peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1 alpha) along with antioxidant, apoptotic (caspase 3, Bax and Bcl2) and inflammatory [nuclear factor kappa-B (NF-kappa B) p65, Interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha) and cyclooxygenase-2 (COX-2)] factors were evaluated in the kidney tissues of the experimental groups. Key findings Eplerenone pre-treatment significantly could improve IR-induced pathological changes and kidney function and increase the renal antioxidant factors compared to the IR group (P < 0.05). Furthermore, in the Eplerenone + IR group, significant elevation of the Klotho, SIRT1, SIRT3 and PGC-1 alpha at the protein level was identified compared to the IR group. Eplerenone pretreatment could not only downregulate NF-kappa B signalling and its downstream inflammatory factors (IL-6, COX-2 and TNF-alpha) but also could decrease apoptotic factors (P <= 0.01). Conclusions The results recommended that Eplerenone exerts a protective effect against kidney IR injury by up-regulating Klotho, HSP70, sirtuins and PGC-1 alpha to preserve mitochondrial function and cell survival. Moreover, it hinders renal inflammation by suppressing NF-kappa B signalling. These results offer insight into the prevention or treatment of in the future.

Automated summary

The study demonstrates that Eplerenone, an aldosterone receptor antagonist, has a protective effect against kidney injury caused by ischemia/reperfusion (I/R). It achieves this by regulating the expression of various proteins related to oxidative stress, inflammation, and apoptosis. These findings provide insights for the prevention or treatment of kidney injury in the future.